Pew Health Group

Pew Health urges Congress to reauthorize PDUFA

Monday, February 6, 2012

Allan Coukell, director of medical programs at the Pew Health Group, issued a statement concerning a U.S. House energy and commerce subcommittee on health hearing on the reauthorization of the Prescription Drug User Fee Act (PDUFA IV), which has shortened the pharmaceutical approval process by the FDA.

[Read More]